Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Pattern To Attend and Present at Biotech Showcase 2025 and the 43rd Annual J.P. Morgan Healthcare Conferences
-
TOMI Environmental Solutions Positioned to Address Growing Global Disease Threats with SteraMist Technology
-
Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors
-
Yerbaé Expands Distribution with Four New Partnerships, Creating Synergies with Safety Shot's Operations
-
American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Delivery of Initial Shipment of American Rebel Light Beer to Kentucky Distribution Partner – Clark Distributing Company
-
SIMPPLE Ltd. CEO Issues Letter to Shareholders
-
Yerbaé Expands Distribution with Four New Partnerships, Creating Synergies with Safety Shot's Operations
-
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
-
Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock
-
Amaero Secures Final Approval for $23.5 Million Loan from Export-Import Bank
-
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
-
Coca-Cola Consolidated CFO Scott Anthony to Retire, Company Names Matt Blickley as New CFO
-
Nutanix to Present at Upcoming Investor Conference
-
Kaival Brands Innovations Group, Inc. and Delta Corp Holdings Limited Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Terranet announces Lars Lindell as new CEO
-
Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
-
LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers
-
Diana Shipping Inc. Announces Time Charter Contract for m/v New York With SwissMarine
-
Rail Vision Receives Purchase Order from One of the Leading Central America Freight Rail Operators
-
Consensus estimates on Tryg A/S
-
Is Spring Break 2025 the Most Expensive Yet? Here's What You Need to Know
-
Issue of Equity and Total Voting Rights
-
Joint Stock Company Kaspi.kz Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court f
-
High Roller Technologies Welcomes Kristofer Muscat as Chief Operating Officer
-
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
-
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
-
BTCS Launches Innovative Staker Protection Plan
-
NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
-
EllisDon’s Executive Chair, Geoff Smith, Honoured with the 2025 Toronto Region Builder Award
-
Diamond Lake Minerals (OTC: DLMI) Acquires Solutions™ Naturopathic & SoftWave Acupuncture Clinics to Pioneer Nationwide Expansion of Non-Invasive Medical Treatments
-
Totus Medicines Announces Successful Completion of a Phase 1 Dose-Escalation Study and Initiation of an Expansion Trial Evaluating TOS-358, a Covalent PI3Ka Selective Therapy for the Treatment of Sele
-
RESTEM Provides Corporate Update and Announces Key Business Objectives for 2025
-
Park Aerospace Corp. Announces Date of Third Quarter Earnings Release and Conference Call
-
Hurco Reports Fourth Quarter and Full Year Results for Fiscal Year 2024
-
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
-
scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
-
Nusano Announces Isotope Availability
-
ORYZON to Provide Corporate Progress Updates at Several Events in January-February
-
XPPen Unveils Artist Pro 22 (Gen 2) with 2.5 K High-Performance 22-inch Drawing Display
-
Galectin Therapeutics to Present at the 2025 MASH-TAG Conference
-
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering
-
Main Street Financial Services Corp. Declares Quarterly Dividend
-
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
-
Pipe17 Raises Series A, Brings on First COO As Demand for AI-Powered Order Operations Takes Off
-
Volcon MN1 Unit Arrives at Cycle Plaza Corpus Christi, Ready to Sell
-
Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates
-
Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement
-
Pulmocide Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
-
Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformati
